03 June 2019
Annual General Meeting Results and Statement
03 June 2019
Annual General Meeting Results and Statement
07 May 2019
Notice of Annual General Meeting
27 February 2019
Results for the year ended 31 December 2018
22 January 2019
Supportive Cardiac Safety Data for BARHEMSYS™
07 December 2018
New BARHEMSYS™ PDUFA date confirmed for 5 May 2019
06 November 2018
Acacia Pharma Resubmits BARHEMSYS™ New Drug Application
06 November 2018
Unaudited Results for the nine months to 30 September 2018
15 October 2018
Further update on FDA regulatory review of BARHEMSYS™
08 October 2018
Update on FDA regulatory review of BARHEMSYS™
07 September 2018
Interim Results for the First Half Year 2018
09 July 2018
Operating Update for the First Half 2018
11 April 2018
US Commercial Operations for BARHEMSYS™ (formerly BAREMSIS®) Expanded Four Key Appointments